rs148579379
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_015627.3(LDLRAP1):c.713G>A(p.Arg238Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000412 in 1,613,998 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R238W) has been classified as Likely benign.
Frequency
Consequence
NM_015627.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLRAP1 | NM_015627.3 | c.713G>A | p.Arg238Gln | missense_variant | 7/9 | ENST00000374338.5 | NP_056442.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDLRAP1 | ENST00000374338.5 | c.713G>A | p.Arg238Gln | missense_variant | 7/9 | 1 | NM_015627.3 | ENSP00000363458.4 | ||
LDLRAP1 | ENST00000484476.5 | n.435G>A | non_coding_transcript_exon_variant | 2/4 | 1 | |||||
LDLRAP1 | ENST00000474283.1 | n.124G>A | non_coding_transcript_exon_variant | 1/3 | 3 | |||||
LDLRAP1 | ENST00000488127.1 | n.1183G>A | non_coding_transcript_exon_variant | 6/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00222 AC: 338AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000539 AC: 135AN: 250684Hom.: 3 AF XY: 0.000428 AC XY: 58AN XY: 135660
GnomAD4 exome AF: 0.000222 AC: 325AN: 1461650Hom.: 1 Cov.: 33 AF XY: 0.000172 AC XY: 125AN XY: 727134
GnomAD4 genome AF: 0.00223 AC: 340AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.00213 AC XY: 159AN XY: 74500
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 4 Benign:4
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 14, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GENinCode PLC | May 07, 2023 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 12, 2023 | Variant summary: LDLRAP1 c.713G>A (p.Arg238Gln) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00054 in 250684 control chromosomes, predominantly at a frequency of 0.0076 within the African or African-American subpopulation in the gnomAD database, including 3 homozygotes. To our knowledge, no occurrence of c.713G>A in individuals affected with Familial Hypercholesterolemia and no experimental evidence demonstrating its impact on protein function have been reported. Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at